Daniil Korenkov

Daniil Korenkov

Auto-generated profile, based on publicly available information

Daniil Korenkov

A Department of Virology , Institute of Experimental Medicine , Saint Petersburg , Russia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2018 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
KCKok Fei Chan
Kok Fei Chan
LCLouise A Carolan
Louise A Carolan
DKDaniil Korenkov
Daniil Korenkov
JDJulian Druce
Julian Druce
JMJames McCaw
James McCaw
KLKaren Laurie
Karen Laurie
Epidemiological studies have observed that the seasonal peak incidence of influenza virus infection is sometimes separate from the peak incidence of human respiratory syncytial virus (hRSV) infection, with the peak incidence of hRSV infection delayed. This is proposed to be due to viral interference, whereby infection with one virus prevents or delays infection with a different virus. We investigated viral interference between hRSV and 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09) in the ferret model. Infection with A(H1N1)pdm09 prevented subsequent infection with hRSV. Infection with hRSV reduced morbidity attributed to infection with A(H1N1)pdm09 but not infection, even when an increased inoculum dose of hRSV was used. Notably, infection with A(H1N1)pdm09 induced higher levels of proinflammatory cytokines, chemokines, and immune mediators in the ferret than hRSV. Minimal cross-reactive serological responses or interferon γ-expressing cells were induced by either virus ≥14 days after infection. These data indicate that antigen-independent mechanisms may drive viral interference between unrelated respiratory viruses that can limit subsequent infection or disease.

2 November 2018 in Expert Review of Vaccines
Verified
Journal Article
Closed access
DKDaniil Korenkov
Daniil Korenkov
IIIrina Isakova-Sivak
Irina Isakova-Sivak
LRLarisa G. Rudenko
Larisa G. Rudenko
One of the essential mechanisms of virus infection control is cell-mediated cytotoxicity, which can act in an antibody-dependent or -independent fashion and is provided by different effector cells. The role of CD8 T-cells in infection control and in affecting the pathological outcome of different types of infection has been demonstrated in numerous animal studies. Despite this, their role in controlling human influenza infection is not fully understood. Especially, knowledge about their induction and turnover in human influenza infection is limited. Differences in the development of CD8 T-cells after influenza infection or immunizations should be explored in detail, in relation to the bioaccessibility of influenza antigens, site of application and distribution routes. This review focuses on the basics of CD8 T-cell immune response both in human influenza infection and after administration of inactivated or live attenuated influenza vaccine. Some aspects of the accessibility, distribution and presentation of influenza antigens to CD8 T-cells are described. The CD8 T-cell response is an essential connection between innate and antibody-mediated responses, which are all-important for influenza control. We hypothesize that immunization with live influenza vaccine is the most straightforward artificial way to induce an efficient influenza-specific CD8 T-cell response.

1 March 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
LRLarisa G. Rudenko
Larisa G. Rudenko
IIIrina Isakova-Sivak
Irina Isakova-Sivak
ANAnatoly Naykhin
Anatoly Naykhin
Irina KiselevaIrina Kiseleva
Irina Kiseleva
SMStukova Marina
Stukova Marina
MKMarie-Paule Kieny
Marie-Paule Kieny

1 May 2018 in Virology
Verified
Journal Article
Closed access
IIIrina Isakova-Sivak
Irina Isakova-Sivak
DKDaniil Korenkov
Daniil Korenkov
TSTatiana Smolonogina
Tatiana Smolonogina
TKTatiana Kotomina
Tatiana Kotomina
SDSvetlana Donina
Svetlana Donina
LRLarisa Rudenko
Larisa Rudenko

3 August 2011 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
PDF file
TCT. V. Chirkova
T. V. Chirkova
ANA. N. Naykhin
A. N. Naykhin
GPGalina Petukhova
Galina Petukhova
DKD. A. Korenkov
D. A. Korenkov
SDS. A. Donina
S. A. Donina
LRLarisa G. Rudenko
Larisa G. Rudenko
Cellular immune responses of both CD4 and CD8 memory/effector T cells were evaluated in healthy young adults who received two doses of live attenuated influenza A (H5N2) vaccine. The vaccine was developed by reassortment of nonpathogenic avian A/Duck/Potsdam/1402-6/68 (H5N2) and cold-adapted A/Leningrad/134/17/57 (H2N2) viruses. T-cell responses were measured by standard methods of intracellular cytokine staining of gamma interferon (IFN-γ)-producing cells and a novel T-cell recognition of antigen-presenting cells by protein capture (TRAP) assay based on the trogocytosis phenomenon, namely, plasma membrane exchange between interacting immune cells. TRAP enables the detection of activated trogocytosis-positive T cells after virus stimulation. We showed that two doses of live attenuated influenza A (H5N2) vaccine promoted both CD4 and CD8 T-memory-cell responses in peripheral blood of healthy young subjects in the clinical study. Significant differences in geometric mean titers (GMTs) of influenza A (H5N2)-specific IFN-γ+cells were observed at day 42 following the second vaccination, while peak levels of trogocytosis+T cells were detected earlier, on the 21st day after the second vaccination. The inverse correlation of baseline levels compared to postvaccine fold changes in GMTs of influenza-specific CD4 and CD8 T cells demonstrated that baseline levels of these specific cells could be considered a predictive factor of vaccine immunogenicity.

11 November 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
GCGloria Gonzalez Curto
Gloria Gonzalez Curto
AVAudrey Der Vartanian
Audrey Der Vartanian
YFYoucef El-Mokhtar Frarma
Youcef El-Mokhtar Frarma
LMLine Manceau
Line Manceau
LBLorenzo Baldi
Lorenzo Baldi
VRVanessa Ribes
Vanessa Ribes
The chromosome translocations generating PAX3-FOXO1 and PAX7-FOXO1 chimeric proteins are the primary hallmarks of the paediatric fusion-positive alveolar subtype of Rhabdomyosarcoma (FP-RMS). Despite the ability of these transcription factors to remodel chromatin landscapes and promote the expression of tumour driver genes, they only inefficiently promote malignant transformationin vivo. The reason for this is unclear. To address this, we developed anin ovomodel to follow the response of spinal cord progenitors to PAX-FOXO1s. Our data demonstrate that PAX-FOXO1s, but not wild-type PAX3 or PAX7, trigger the trans-differentiation of neural cells into FP-RMS-like cells with myogenic characteristics. In parallel, PAX-FOXO1s remodel the neural pseudo-stratified epithelium into a cohesive mesenchyme capable of tissue invasion. Surprisingly, expression of PAX-FOXO1s, similar to wild-type PAX3/7, reduce the levels of CDK-CYCLIN activity and increase the fraction of cells in G1. Introduction of CYCLIN D1 or MYCN overcomes this PAX-FOXO1-mediated cell cycle inhibition and promotes tumour growth. Together, our findings reveal a mechanism that can explain the apparent limited oncogenicity of PAX-FOXO1 fusion transcription factors. They are also consistent with certain clinical reports indicative of a neural origin of FP-RMS.